How do dogs respond to COVID-19? Getty/Darian Traynor The coronavirus pandemic is often discussed in terms of waves. First waves, second waves. The information surrounding the pandemic works in a similar way, particularly as scientists learn more about how the disease spreads and who -- or what -- it infects.Several companion animals tested positive for…
It won't be a slam dunk for vaccines to turn the tide against the pandemic. A safe and effective vaccine would be a shot in the arm for a world that's grown weary of the COVID-19 pandemic. The good news is that there's a lot of work going on to produce just such a vaccine.…
Whatever we do with contentious or controversial statues and monuments, it should not be the outcome of the random acts of populist mobilisation. Building inclusive societies is the result of thoughtful and collective deliberation, argue Adam Habib and Alexandra Leisegang.Statues across the world are being torn down, vandalised, in response to legitimate anger about racism and…
South Carolina has permitted retail stores to reopen to customers. It's one of a handful of states easing up on some social distancing restrictions. Dustin Chambers/Bloomberg via Getty Images hide caption toggle caption Dustin Chambers/Bloomberg via Getty Images South Carolina has permitted retail stores to reopen to customers. It's one of a handful of states…
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment